The role of apoptosis in vascular disease

Journal of Pathology

Volumn 190, Issue 3, 2000, Pages 267-280

  Kockx, Mark M ^a,b,d   Knaapen, Michiel W M ^c  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Applied Cardiovascular Morphology   (Belgium)

^d NONE   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; Bax; DNA repair; Lipid lowering; Macrophages; Plaque rupture; Smooth muscle cells

Indexed keywords

THROMBIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DNA REPAIR; DNA SYNTHESIS; ENDOTHELIUM CELL; HYPERTENSION; MACROPHAGE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULAR DISEASE;

APOPTOSIS; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; DNA REPAIR; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR;

EID: 0034009935     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:3<267::AID-PATH523>3.0.CO;2-A     Document Type: Review

References (138)

1. Virchow R. Die Cellularpathologie: Sechszehnte Vorlesung, 14 April 1858. George Olms: Hildesheim, 1966; 317-329.
2. Imai H, Thomas WA. Cerebral atherosclerosis in swine: role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp Mol Pathol 1968; 8: 330-357.
3. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
4. Saunders JW. Death in embryonic systems. Science 1966; 154: 604-612.
5. Cho A, Cantman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 1995; 76: 168-175.
6. Slomp J, Gittenberger-de Groot AC, Glukhova MA, et al. Differentiation, dedifferentiation and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol 1997; 17: 1003-1009.
7. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-2711.
8. Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol 1996; 180: 423-429.
9. Kockx MM, De Meyer GRY, Muhring J, et al. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis 1996; 120: 115-124.
10. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin 1β converting enzyme. Am J Pathol 1995; 147: 251-266.
11. Han DKM, Haudenschild CC, Hong MK, et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-277.
12. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149: 367-380.
13. Mallat Z, Ohan J, Lesėche G, Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation 1997; 96: 424-428.
14. Newby AC, George SJ. Proliferation, migration, matrix turnover and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol 1996; 11: 574-582.
15. Bauriedel G, Schluckebier, Hutter R, et al. Apoptosis in restenosis versus stable angina attherosclerosis. Implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 1998; 18: 1132-1139.
16. Kockx MM, De Meyer GRY, Bortier H, et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation 1996; 94: 1255-1262.
17. Kockx MM, De Meyer GRY, Muhring J, et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97: 2307-2315.
18. Bennet MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266-2274.
19. Kockx MM. Apoptosis in the atherosclerotic plaque. Quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol 1998; 18: 1519-1522.
20. Kockx MM, Herman AG. Apoptosis in atherogenesis: Implications for plaque destabilization. Eur Heart J 1998; 19 (Suppl G): G23-G28.
21. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999; 41: 361-368.
22. Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH. Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease. Nature Med 1998; 4: 222-227.
23. Wang BY, Ho HKV, Lin PS, et al. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation 1999; 99: 1236-1241.
24. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
25. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of the endonuclease. Am J Pathol 1990; 136: 593-608.
26. Wyllie AH, Morris RG, Smith A, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
28. Kockx MM, Muhring J, Bortier H, De Meyer GRY, Jacob W. Biotin or digoxigenin conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol 1996; 148: 1771-1777.
29. Hegyi L, Hardwick SJ, Mitchinson MJ. Letter to the editor. Am J Pathol 1997; 105: 371-373.
30. Kockx MM, Muhring J, Knaapen MWM. De Meyer GRY. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 1998; 152: 885-888.
31. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
32. Song Q, Lees-Miller SP, Kumar S, et al. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J 1996; 15: 3238-3246.
33. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757-30760.
34. Messmer UK, Reimer DM, Brune B. Protease activation during nitric oxide-induced apoptosis: comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage. Eur J Pharmacol 1998; 349: 333-343.
35. Biggiogera M, Bottone MG, Pelicciari C. Nuclear RNA is extruded from apoptotic cells. J Histochem Cytochem 1998; 46: 999-1005.
36. Murer-Orlando ML, Peterson AC. In situ nick translation of human and mouse chromosomes detected with biotinylated nucleotide. Exp Cell Res 1985; 157: 322-334.
37. Adolph S, Hamaster H. In situ nick translation of metaphase chromosomes with biotin-labelled d-UTP. Hum Genet 1985; 69: 117-121.
38. Anasari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8.
39. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
40. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
41. Sarasta A, Pulkki K, Kallajoki, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 1999; 29: 380-386.
42. Rayment NB, Haven AJ, Madden B, et al. Myocyte loss in chronic heart failure. J Pathol 1999; 188: 213-219.
43. Davies MJ. Apoptosis in cardiovascular disease. Heart 1997; 77: 498-501.
44. Sarasta A. Morphologic criteria and detection of apoptosis. Herz 1999; 24: 189-195.
45. Schaper J, Lorenz-Meyer S, Suzuki K. The role of apoptosis in dilated cardiomyopathy. Hez 1999; 24: 219-224.
46. Kanoh M, Takemura G, Misao J, et al. Significance of myocytes with positive DNA in situ nick end labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999; 99: 2757-2764.
47. Lutgens E, Daemen M, Kockx M, et al. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation 1999; 99: 276-283.
48. Lutgens E, De Muinck ED, Kitslaar PJ, et al. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 1999; 41: 473-479.
49. Polte T, Oberle S, Schröder H. Nitric oxide protects endothelial cells from tumor necrosis factor-α-induced cytotoxicity: possible involvement of cyclic GMP. FEBS Lett 1997; 409: 46-48.
50. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1a-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like protease. J Exp Med 1997; 185: 601-607.
51. Dimmeler S, Haendeler J, Sause A, Zeiher AM. Nitric oxide inhibits Apo-1/Fas-mediated cell death. Cell Growth Diff 1998; 9: 415-422.
52. Buttery LDK, Springall DR, Chester AH, et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75: 77-85.
53. Wilcox JN, Subramanian RR, Sundell CL, et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997; 17: 2479-2488.
54. Luoma JS, Strålin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998; 18: 157-167.
55. Esaki T, Hayashi T, Muto E, et al. Expression of inducible nitric oxide synthase in T-lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 1997; 128: 39-46.
56. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem 1994; 375: 81-88.
57. Cromheeke KM, Kockx MM, De Meyer GRY, et al. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/ peroxidation in human atherosclerotic plaques. Cardiovasc Res 1999; 9: 744-754.
58. Dimmeler S, Hermann C, Zeiher AM. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw 1998; 9: 697-698.
59. Du XL, Sui GZ, Stockklauser-Farber K, et al. Introduction of apoptosis by high pro-insulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia 1998; 41: 249-256.
60. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP-32 like proteases. Circulation 1997; 95: 1760-1763.
61. Lizard G, Lemaire S, Monier S, et al. Induction of apoptosis and of interleukin-1-beta secretion by 7-beta-hydroxycholesterol and 7-ketocholesterol: partial inhibition by Bcl-2 overexpression. FEBS Lett 1997; 419: 276-280.
62. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81: 970-976.
63. Erl W, Hansson GK, de Martin R, et al. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells Circ Res 1999; 84: 668-677.
64. Schwartz SM. Smooth muscle proliferation in hypertension. State-of-the-art lecture. Hypertension 1984; 6: 56-61.
65. Campbell JH, Tachas G, Black MJ, Cockerill G, Campbell GR. Molecular biology of vascular hypertrophy. Basic Res Cardiol 1991; 86: 3-11.
66. Diez J, Panizo A, Hernández M, Pardo J. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension 1997; 29: 776-780.
67. Champagne MJ, Dumas P, Orlov SN, et al. Protection against necrosis but not apoptosis by heat-stress proteins in vascular smooth muscle cells: evidence for distinct modes of cell death. Hypertension 1999; 33: 906-913.
68. Sharifi AM, Schiffrin EL. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism. J Hypertens 1997; 15: 1441-1448.
69. Sharifi AM, Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens 1998; 11: 1108-1116.
70. Hamet P. What is apoptosis and what is its relevance to vascular biology? Can J Cardiol 1999; 15: 5B-7B.
71. Bennett MR, Evan GI, Newby AC. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res 1994; 74: 525-536.
72. Bai HA, Pollman MJ, Inishi Y, Gibbons GH. Regulation of vascular smooth muscle cell apoptosis: modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 1999; 85: 229-237.
73. Tagami M, Yamagata K, Ikeda K, et al. Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23-29.
74. Fortuño MA, Zalba G, Ravassa S, et al. p53-mediated upregulation of BAX gene transcription is not involved in bax-alpha protein overexpression in the left ventricle of spontaneously hypertensive rats. Hypertension 1999; 33: 1348-1352.
75. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997; 95: 981-987.
76. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliére A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146: 1059-1064.
77. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I Smooth muscle cell growth in the absence of endothelium. Lab Invest 1983; 49: 327-333.
78. Igase M, Okura T, Kitami Y, Hiwada K. Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries. Clin Sci 1999; 96: 605-612.
79. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-394.
80. Sata M, Perlman H, Muruve DA, et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci U S A 1998; 95: 1213-1217.
81. Steg PG, Tahlil O, Aubailly N, et al. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation 1997; 96: 408-411.
82. Waksman R, Rodriguez JC, Robinson KA, et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997; 96: 1944-1953.
83. Libby P, Geng YJ, Aikawa M, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7: 330-335.
84. Arroyo LH, Lee RT. Mechanism of plaque rupture: mechanical and biologic interactions. Cardiovasc Res 1999; 41: 369-375.
85. Van der Wal AC, Becker AE. Atherosclerotic plaque rupture -pathologic basis of plaque stability and instability. Cardiovasc Res 1999; 41: 334-344.
86. Gallis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503.
87. Newby AC, Zaltsman AB. Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 1999; 41: 345-360.
88. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 1999; 41: 376-384.
89. Ang AH, Tachas G, Campbell JH, Bateman JF, Campbell GR. Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. Biochem J 1999; 265: 461-469.
90. Rekhter MD, Gordon D. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J Vasc Res 1994; 31: 280-286.
91. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995; 80; 293-299.
92. Iacopetta B, Wysocki S, Norman P, House A. The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol 1995; 7: 399-402.
93. Woo RA. McLure KG, Lees-Miller SP, Rancourt DE, Lee PW. DNA dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 1998; 394: 700-704.
94. Kockx MM, De Meyer GRY, Buyssens N, et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 1998; 83: 378-387.
95. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984; 114: 79-93.
96. Stehbens WE. Cerebral atherosclerosis: intimal proliferation and atherosclerosis in the cerebral arteries. Arch Pathol 1975; 999: 582-591.
97. Boyle JJ, Bowyer DE, Proudfoot D, Weisberg PL, Bennett MR. Human monocyte/macrophages induce human vascular smooth muscle cell apoptosis in culture. Circulation 1998; 98: 598.
98. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Involvement of the Fas death-signalling pathway in cytokine-induced apoptosis of vascular smooth muscle cells during atherogenesis. Arterioscler Thromb Vasc Biol 1997; 17: 2200-2208.
99. Cai W, Devaux B, Schaper W. Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 1997; 131: 177-186.
100. Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary artery disease: pathologic evidence for Fas mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 1996; 74: 921-931.
101. Best PJM, Hasdai D. Sangiorgi, et al. Apoptosis: basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol 1999; 19: 14-22.
102. Flynn PD, Byrne CD, Baglin TP, Weissberg PL, Bennett MR. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 1997; 89: 4378-4384.
103. Stuart MC, Damoiseaux JG, Frederik PM. Arends JW, Reutelingspergecr CP. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes. Ear J Cell Biol 1998; 76: 77-83.
104. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-1003.
105. Nguyen T, Brunson D, Crespi CL, et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1998; 89: 3030-3034.
106. De Rojas-Walker T, Tamir S, Ji H, Wishnok JS, Tannenbaum SR. Nitric oxide induces oxidativc damage in addition to deamination in macrophage DNA. Chem Res Toxicol 1995; 8: 473-477.
107. White E. p53, guardian of Rb. Nature 1994; 371: 21-22.
108. Ihling C, Menzel G, Wellens E, et al. Topographical association between cyclin-dependent kinases inhibitor p21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 1997; 17: 2218-2224.
109. Guevara NV, Kim HS, Antonova El, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nature Med 1999; 5: 335-339.
110. Meßmer UK, Reed JC, Bru7die;ne B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 1996; 271: 20192-20197.
111. Althaus FR, Richter C. ADP ribosylation of proteins enzymology and biological significance. Mol Biol Biochem Biophys 1987; 37: 1-237.
112. De Murcia G, Menessier-De Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994; 19: 172-176.
113. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 1996; 93: 1753-1758.
114. Henry Y, Lepoivre M. Drapier JC. et al. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 7: 1124-1134.
115. Kim YK, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997; 272: 31138-31148.
116. Melino G, Bernassola F, Knight RA, et al. S-Nitrosylation regulates apoptosis. Nature 1997; 388: 432-433.
117. Mannick JB, Hausladen A, Liu L. et al. Fas-induced caspase denitrosylation. Science 1999; 284: 651-654.
118. Bobryshev YV, Babaev VR, Lord RSA, Watanabe T. Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis. In vivo 1997; 11: 441-452.
119. Ball RY, Stowers EC, Burton JH, et al. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 1995; 114: 45-54.
120. Crisby M, Kallin B, Thyberg J, et al. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 1997; 130: 17-27.
121. Vercammen D, Beyaert G, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477-1485.
122. Majno G, Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol 1995; 146: 3-15.
123. Lizard G. Monier S. Cordelet C, et al. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7-beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol 1999; 19: 1190-1200.
124. Platt N, Da Silva RP, Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol 1998; 8: 365-372.
125. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 1997; 53: 491-508.
126. Sambrano GR, Parthasarathy S, Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1994; 91: 3265-3269.
127. Sambrano GR, Steinberg D. Recognition of oxidative and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A 1995; 92: 1396-1400.
128. Steinberg D, Lewis A. Conner Memorial Lecture: oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062-1071.
129. Burke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.
130. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 1997; 8: 275-280.
131. Knies UE, Behrensdorf HA, Mitchell CA, et al Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci U S A 1998; 95: 12322-12327.
132. Kao J, Houck K, Fan Y, et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem 1994; 269: 25106-25119.
133. Loegering DJ, Raley MJ, Reho TA, Eaton JW. Macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: production of lipid peroxidation products. J Leukoc Biol 1996; 59: 357-362.
134. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-2442.
135. Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 281-289.
136. Toschi V, Gallo G, Lettino M, et al. Tissue factor modulates thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-599.
137. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353.
138. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998; 97: 2433-2444.